PowerShares Dynamic Pharmaceuticals Portfolio (PJP)
| 42.82 Data as of May 17 |  +0.25 / +0.59%Today’s Change | 28.50 Today|||52-Week Range 43.77 | +24.01% Year-to-Date |
Investment Objective
The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceuticals IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. It is non-diversified.
Latest PJP News
No recent news for PowerShares Dynamic Pharmaceuticals Portfolio.
Performance
| 1 month | +5.86% | 3 years | +32.37% | |
| 3 months | +14.11% | 5 years | +21.10% | |
| 1 year | +40.98% | Since inception | +15.26% |
Data through 05/18/2013
Quote Details
| Previous close | $42.57 |
| Open day’s range | 42.40 – 42.82 |
| Net asset value (NAV) | 42.79 (05/17/2013) |
| Daily volume | 88,844 |
| Average volume (3 months) | 109,424 |
Data as of 3:59pm ET, 05/17/2013
Peer Comparisonvs. Health ETFs
| PJP | Category | |
|---|---|---|
| Performance 5-yr return | +21.10% | +13.03% |
| Expense Gross exp ratio | 0.64% | 0.47% |
| Risk 5 year sharpe ratio | 1.22 | 0.75 |
| Net assets | $468.3M | $776.1M |
| Average market cap | $15.8B | $19.4B |
| Average P/E | 20.4 | 21.6 |
| Dividend / Share | -- | 0.22% |
Competitors
| VHT Vanguard Health Care ETF |
| XLV Health Care Select Sector SPDR Fund |
| IYH iShares Dow Jones US Healthcare Sector I... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 97.52% |
| Consumer goods | 2.48% |
| Business service | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen Inc | 5.52% |
| GILD Gilead Sciences Inc | 5.49% |
| JNJ Johnson & Johnson | 5.14% |
| MRK Merck & Co Inc | 5.03% |
| BMY Bristol-Myers Squibb Company | 4.95% |
| ABT Abbott Laboratories | 4.92% |
| PFE Pfizer Inc | 4.89% |
| LLY Eli Lilly and Company | 4.70% |
| SNTS Santarus, Inc. | 3.49% |
| BIIB Biogen Idec Inc | 3.34% |